MX9604551A - Uso de fosfonilmetoxialquilnucleosidos para el tratamiento de presion intraocular elevada. - Google Patents

Uso de fosfonilmetoxialquilnucleosidos para el tratamiento de presion intraocular elevada.

Info

Publication number
MX9604551A
MX9604551A MX9604551A MX9604551A MX9604551A MX 9604551 A MX9604551 A MX 9604551A MX 9604551 A MX9604551 A MX 9604551A MX 9604551 A MX9604551 A MX 9604551A MX 9604551 A MX9604551 A MX 9604551A
Authority
MX
Mexico
Prior art keywords
injection
pressure
intraocular pressure
phosphonylmethoxyalkyl
administration
Prior art date
Application number
MX9604551A
Other languages
English (en)
Other versions
MXPA96004551A (es
Inventor
William R Freeman
Original Assignee
William R Freeman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William R Freeman filed Critical William R Freeman
Priority claimed from PCT/US1995/004047 external-priority patent/WO1995026734A1/en
Publication of MXPA96004551A publication Critical patent/MXPA96004551A/es
Publication of MX9604551A publication Critical patent/MX9604551A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan métodos para el tratamiento de condiciones de la presion intraocular aumentada anormalmente, en forma particular aquellos provocados por el glaucoma, mediante la administracion de análogos fosfonilmetoxialquil-nucleosidos. También se proporcionan composiciones formuladas y envasadas para la administracion intraocular para utilizarse en los métodos. La administracion del compuesto puede ser por medio de inyeccion intravítrea, inyeccion de humor acuoso, inyeccion en las capas externas para el ojo, se utilizan tales como inyeccion subconjuntiva o inyeccion subtenon o pueden ser cuando los derivados son penetrados por aplicacion topica al ojo. Los grados de reduccion en la presion es dependiente de la dosis y reduccion significativa en la presion es obtenida. Una sola inyeccion puede producir disminucion de la presion intraocular prolongada y quizá permanente.
MX9604551A 1994-12-20 1995-03-31 Uso de fosfonilmetoxialquilnucleosidos para el tratamiento de presion intraocular elevada. MX9604551A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08222128 1994-04-04
US36099594A 1994-12-20 1994-12-20
US360,995 1994-12-20
US360995 1994-12-20
PCT/US1995/004047 WO1995026734A1 (en) 1994-04-04 1995-03-31 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure

Publications (2)

Publication Number Publication Date
MXPA96004551A MXPA96004551A (es) 1998-02-01
MX9604551A true MX9604551A (es) 1998-02-28

Family

ID=39164935

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9604551A MX9604551A (es) 1994-12-20 1995-03-31 Uso de fosfonilmetoxialquilnucleosidos para el tratamiento de presion intraocular elevada.

Country Status (1)

Country Link
MX (1) MX9604551A (es)

Similar Documents

Publication Publication Date Title
HK1007102A1 (en) Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
EP1225168A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
CA2129287A1 (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
IE811654L (en) Ophthalmic composition
IE873449L (en) 3-aryloxypropanamine derivatives
CA2027608A1 (en) Hair revitalizing agent
GR3037008T3 (en) Treatment of ocular hypertension with beta-blockers and derivatives of protanoic acid.
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
EP0917873A4 (en) EYE DROP
IE810785L (en) Anti-inflammatory ophthalmic composition
WO1996016647A3 (en) Use of chloride channel blockers for reducing intraocular pressure
ES8401927A1 (es) Procedimiento de obtencion de composiciones oftalmologicas.
WO1992000287A3 (en) Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
MX9604551A (es) Uso de fosfonilmetoxialquilnucleosidos para el tratamiento de presion intraocular elevada.
UA41880C2 (uk) Серотонінергічні похідні ерголіну і фармацевтична композиція
EP0345028A3 (en) Treatment of glaucoma using phosphodiesterase inhibitor
NO942756L (no) Behandling av glaucoma
CA2139781A1 (en) Ophthalmic topical composition containing (s)-timolol hemihydrate
AP2002002595A0 (en) Heterocyclic amide derivatives.
BR0209601A (pt) Método para o tratamento da hipertensão ocular e do glaucoma
NZ508246A (en) Method of treating a condition that can be treated by decreasing intraocular pressure in a non-human mammal
CA2065889A1 (en) Increasing the choroidal blood flow
CA2171462A1 (en) Compounds for the prevention and treatment of helminth infections
JPS5513241A (en) Remedy for glaucoma
JPS55102516A (en) Remedy for glaucoma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal